These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35149265)

  • 1. Quinolinyl sulfonamides and sulphonyl esters exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Chigan JZ; Hu Z; Liu L; Xu YS; Ding HH; Yang KW
    Bioorg Chem; 2022 Mar; 120():105654. PubMed ID: 35149265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.
    Liu L; Xu YS; Chigan JZ; Zhai L; Ding HH; Wu XR; Chen WY; Yang KW
    Bioorg Chem; 2022 Oct; 127():105928. PubMed ID: 35717802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.
    Wu XR; Chen WY; Liu L; Yang KW
    Eur J Med Chem; 2024 Feb; 265():116055. PubMed ID: 38134748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Ge Y; Kang PW; Li JQ; Gao H; Zhai L; Sun LY; Chen C; Yang KW
    J Antibiot (Tokyo); 2021 Sep; 74(9):574-579. PubMed ID: 34234284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.
    Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW
    Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo.
    Su J; Liu J; Chen C; Zhang Y; Yang K
    Bioorg Chem; 2019 Mar; 84():192-201. PubMed ID: 30502631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino Acid Thioesters Exhibit Inhibitory Activity against B1-B3 Subclasses of Metallo-β-lactamases.
    Zhang YJ; Liu XL; Wang WM; Chen C; Zhao MH; Yang KW
    Chem Pharm Bull (Tokyo); 2019; 67(2):135-142. PubMed ID: 30713274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatic Schiff bases confer inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhai L; Jiang Y; Shi Y; Lv M; Pu YL; Cheng HL; Zhu JY; Yang KW
    Bioorg Chem; 2022 Sep; 126():105910. PubMed ID: 35653899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1.
    Gao H; Li JQ; Kang PW; Chigan JZ; Wang H; Liu L; Xu YS; Zhai L; Yang KW
    Bioorg Chem; 2021 Sep; 114():105138. PubMed ID: 34229201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.
    Ge Y; Xu LW; Liu Y; Sun LY; Gao H; Li JQ; Yang K
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
    Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
    Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.
    Li X; Zhao D; Zhao X; Cheng P; Li F; Sun J; Li Y; Bai J; Zhang X
    Eur J Med Chem; 2023 Mar; 250():115225. PubMed ID: 36870273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azolylthioacetamides as potential inhibitors of New Delhi metallo-β-lactamase-1 (NDM-1).
    Liu XL; Xiang Y; Chen C; Yang KW
    J Antibiot (Tokyo); 2019 Feb; 72(2):118-121. PubMed ID: 30449891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent research and development of NDM-1 inhibitors.
    Wang T; Xu K; Zhao L; Tong R; Xiong L; Shi J
    Eur J Med Chem; 2021 Nov; 223():113667. PubMed ID: 34225181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
    Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
    Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.
    Li JQ; Gao H; Zhai L; Sun LY; Chen C; Chigan JZ; Ding HH; Yang KW
    Bioorg Med Chem; 2021 May; 38():116128. PubMed ID: 33862468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhang YL; Yang KW; Zhou YJ; LaCuran AE; Oelschlaeger P; Crowder MW
    ChemMedChem; 2014 Nov; 9(11):2445-8. PubMed ID: 25048031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1.
    Jackson AC; Pinter TBJ; Talley DC; Baker-Agha A; Patel D; Smith PJ; Franz KJ
    ChemMedChem; 2021 Feb; 16(4):654-661. PubMed ID: 33211374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Bromopyruvate as a potent covalently reversible inhibitor of New Delhi metallo-β-lactamase-1 (NDM-1).
    Kang PW; Su JP; Sun LY; Gao H; Yang KW
    Eur J Pharm Sci; 2020 Jan; 142():105161. PubMed ID: 31751778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Cisplatin and Palladium(II) Complexes as Potent Metallo-β-lactamase Inhibitors for Targeting Carbapenem-Resistant
    Chen C; Sun LY; Gao H; Kang PW; Li JQ; Zhen JB; Yang KW
    ACS Infect Dis; 2020 May; 6(5):975-985. PubMed ID: 32119777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.